February 2025 – Jissan Cherian, President & Founder of DVERSFY, continues to break new ground in the tech industry as he takes on an exciting new role as Executive Advisor for SINTA AI, a tech startup focused on unlocking the growth potential of existing data within the Consumer Healthcare and Pharma industries. Cherian, who remains the President & Founder of DVERSFY, is embracing this next phase in his career with great enthusiasm, further solidifying his expertise in both technology and business leadership.
SINTA AI, a company known for its advanced AI-driven solutions, is poised for continued growth with Cherian’s strategic insights and 20 years of tech, consulting, and marketing experience. As Executive Advisor, Cherian will work closely with the C-Suite leadership team at SINTA AI to steer the company through its next phase of development, focusing on leveraging AI to uncover hidden insights in the vast amount of data behind Consumer Healthcare’s largest brands.
Cherian’s impact on the AI sector doesn’t stop there—he will also be presenting alongside the CEO of SINTA AI at the highly anticipated 2025 CHPA (Consumer Healthcare Products Association) Annual Self Care Leadership Summit, taking place from March 17-19 at the La Cantera Resort & Spa in San Antonio, Texas. This prestigious event will feature a series of groundbreaking sessions, including the Learning Lab “Unlocking Hidden Insights in Consumer Healthcare: AI’s Role in Driving Brand Differentiation” session on Tuesday, March 18, where Cherian will share the stage with Philip Penalosa, CEO of SINTA AI. Together, they will explore how SINTA AI’s cutting-edge algorithms are transforming clinical data and consumer research into actionable insights, fueling product innovation, and enhancing brand experiences.
This session will be part of a larger program featuring leaders in AI, including “Leadership 2030: The Transformative Power of Generative AI on Leaders and Organizations”, hosted by Joseph Fuller, Professor of Management Practice at Harvard Business School. Attendees will gain invaluable insights into how generative AI is revolutionizing corporate functions and driving competitive advantage.
“I’m thrilled to join this distinguished group of AI thought leaders at the 2025 CHPA Annual Self-Care Leadership Summit,” Cherian said. “It’s always inspiring when the CHPA community comes together, representing the top manufacturers and marketers of Consumer Healthcare OTC brands. I’m excited to contribute to the discussion on how AI can unlock new growth opportunities for organizations and brands in the consumer healthcare space. This is a great opportunity to share how SINTA AI’s solutions are empowering brands to make data-driven decisions that create meaningful impact.”
As part of his role at SINTA AI, Cherian is also excited to advise the company’s talented leadership team, including CEO Philip Penalosa. Cherian’s deep understanding of consumer healthcare, combined with his decade-long experience in building iconic brands, positions him as a key driver of SINTA AI’s mission. “I’m looking forward to advising Philip and the talented team at SINTA AI to help healthcare brands unlock the full potential of their existing data,” Cherian stated. “SINTA AI solutions have the power to supercharge data-driven strategies, fueling incremental innovation, impactful claims development, and differentiated brand strategies.”
SINTA AI is revolutionizing the consumer healthcare and pharma sectors, helping brands leverage AI to drive innovation and optimize consumer research. Cherian’s guidance will further strengthen the company’s ability to bridge the gap between marketing and R&D, empowering healthcare brands to make smarter, data-driven decisions.
To learn more about DVERSFY, please visit www.dversfygroup.com
About Jissan Cherian
Jissan Cherian is an accomplished marketing leader with over 20 years of experience across Consumer Healthcare, Technology, and Management Consulting. As the former Senior Director of the U.S. Digestive Health portfolio at Haleon/GlaxoSmithKline (GSK), Jissan led a $1 billion portfolio of iconic brands such as TUMS, Benefiber, Nexium, and Preparation-H, driving brand equity and consumer loyalty through innovative marketing strategies, digital excellence, and a focus on customer-first solutions. Jissan also led the successful U.S. Rx-to-OTC Switch launch of Voltaren Arthritis Pain Gel, a milestone achievement that expanded access and self-care to millions of arthritis and joint pain consumers. Jissan’s career began at Microsoft, where he joined as a Technologist in the SAP-ERP division. His ability to translate technical solutions into business value quickly set him apart, earning him the opportunity to lead Microsoft’s first Disaster Recovery/Business Continuity initiative. From Microsoft, he transitioned to Deloitte Consulting, where he leveraged his technical background to optimize business processes for major clients in retail, banking, and consumer goods.
Jissan earned his BBA in Management Information Systems from The University of Texas at Austin and his MBA in Marketing, Strategy, and International Management from Carnegie Mellon University. In 2025, Jissan earned an Executive Certification in Artificial Intelligence (AI) from MIT Sloan School of Management.
